EGFR and cancer: The remarkable binding performance shown by MIN towards proteins has definitely widened MIN applications in biomedicine, being recently focused on targeting surface receptor proteins expressed on cancer cells [8], such as the epidermal growth factor receptors (EGFR) [9] or the vascular endothelial growth factor (VEGF) [10].